AI assistant
Altimmune, Inc. — Director's Dealing 2025
Jan 29, 2025
33207_dirs_2025-01-28_7332a52a-26b4-4368-877a-9e203e94e0f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Altimmune, Inc. (ALT)
CIK: 0001326190
Period of Report: 2025-01-25
Reporting Person: Roberts M Scot (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-25 | Common Stock, par value $0.0001 | M | 14600 | — | Acquired | 57910 | Direct |
| 2025-01-25 | Common Stock, par value $0.0001 | F | 4264 | $6.98 | Disposed | 53646 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-25 | Restricted Stock Units | $ | M | 14600 | Acquired | Common Stock, par value $0.0001 (14600) | Direct | |
| 2025-01-27 | Stock Options (option to buy) | $7.00 | A | 183600 | Acquired | 2035-01-27 | Common Stock, par value $0.0001 (183600) | Direct |
| 2025-01-27 | Restricted Stock Units | $ | A | 63400 | Acquired | Common Stock, par value $0.0001 (63400) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.0001 | 15 | Indirect |
Footnotes
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
F2: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
F3: The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
F4: Twenty-five percent of the shares underlying the option become vested and released on January 27, 2026 and the remaining 75% of the shares underlying the option become vested and released in substantially equal monthly installments over the 36 months following January 27, 2026, subject to the reporting person's continued service through the applicable vesting date.
F5: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.